Announces encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with apalutamide in patients with mCRPC. Entered into clinical tr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback